SGTX

Sigilon Therapeutics, Inc. Common Stock
SGTX

Overview Fund Activity
Delisted

SGTX was delisted on the 10th of August, 2023.

Back to rankings

16 hedge funds and large institutions have $26.6M invested in Sigilon Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 9 reducing their positions, and 19 closing their positions.

Holders
16
Holders Change
-16
Holders Change %
-50%
% of All Funds
0.25%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
1
Reduced
9
Closed
19
Calls
$293K
Puts
–
Net Calls
+$293K
Net Calls Change
+$267K

Top Buyers

1
YCM
1
Yakira Capital Management
Connecticut
$895K
2
CL
2
CSS LLC
Illinois
$299K
3
TRCT
3
Tower Research Capital (TRC)
New York
$46.6K
4
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
$3K

Top Sellers

1
BlackRock
1
BlackRock
New York
$5.7K
2
CM
2
Cercano Management
Washington
$0
3
Morgan Stanley
3
Morgan Stanley
New York
$144K
4
Millennium Management
4
Millennium Management
New York
$0
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
VF
26
Virtu Financial
New York
– -$26K -2,123 Closed
GSC
27
Ground Swell Capital
South Carolina
– -$23.8K -1,972 Closed
SWM
28
Soundmark Wealth Management
Washington
– -$23.8K -1,966 Closed
Northern Trust
29
Northern Trust
Illinois
– -$22.4K -1,853 Closed
RJA
30
Raymond James & Associates
Florida
– -$20.8K -1,723 Closed
Prudential Financial
31
Prudential Financial
New Jersey
– -$9.86K -815 Closed
Barclays
32
Barclays
United Kingdom
– -$2K -180 Closed
Federated Hermes
33
Federated Hermes
Pennsylvania
– -$1.19K -98 Closed
UBS Group
34
UBS Group
Switzerland
– -$658 -54 Closed
NECFA
35
New England Capital Financial Advisors
Connecticut
– -$38 -3 Closed
1
2